Abstract
Two novel single nucleotide polymorphisms (SNPs; rs7529229 and rs2228145) in the interleukin-6 receptor (IL6R) gene have recently been associated with coronary heart disease (CHD) in a European population. We sought to replicate this finding and to investigate associations of these two SNPs with the severity and clinical phenotypes of premature CHD in a Chinese Han population. A total of 418 patients were studied, including 187 cases with coronary stenosis ≥50 % or acute myocardial infarction (males < 55 years and females < 65 years) and 231 controls without documented CHD. A ligase detection reaction was performed to detect rs7529229 and rs2228145. There were no differences between the controls and premature CHD groups in the frequencies for the three genotypes and alleles of rs7529229 and rs2228145 (all P > 0.05), nor did they differ between the two groups when grouped by gender (all P > 0.05). There were also no associations between these two SNPs and the severity of coronary lesions or clinical phenotypes of premature CHD (all P > 0.05). Our results do not support an association between rs7529229 or rs2228145 with premature CHD in the Chinese Han population. Further studies are warranted to elucidate the role of these two SNPs in the development of atherosclerosis and CHD.
Similar content being viewed by others
References
He J, Gu D, Wu X et al (2005) Major causes of death among men and women in China. N Engl J Med 353:1124–1134
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695
Harismendy O, Notani D, Song X et al (2011) 9p21 DNA variants associated with coronary artery disease impair interferon-γ signaling response. Nature 470:264–268
Schoester M, Heinrich PC, Graeve L (1994) Regulation of interleukin-6 receptor expression by interleukin-6 in human monocytes–a re-examination. FEBS Lett 345:131–134
Kopf M, Baumann H, Freer G et al (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339–342
Chu NF, Lin FH, Chin HC et al (2011) Association between interleukin-6 receptor gene variations and atherosclerotic lipid profiles among young adolescents in Taiwan. Lipids Health Dis 10:136
Yudkin JS, Kumari M, Humphries SE et al (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209–214
Naka T, Nishimoto N, Kishimoto T (2002) The paradigm of IL-6: from basic science to medicine. Arthritis Res 4:S233–S242
Yamasaki K, Taga T, Hirata Y et al (1988) Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 241:825–828
Hibi M, Murakami M, Saito M et al (1990) Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63:1149–1157
Rose-John S, Waetzig GH, Scheller J et al (2007) The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11:613–624
Boulanger MJ, Chow DC, Brevnova EE et al (2003) Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 300:2101–2104
Ridker PM, Rifai N, Stampfer MJ et al (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767–1772
Danesh J, Kaptoge S, Mann AG et al (2008) Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 5:e78
Sattar N, Murray HM, Welsh P et al (2009) Prospective study of pravastatin in the elderly at risk (PROSPER) study group. Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Med 6:e1000099
Kluck PM, Wiegant J, Jansen RP et al (1993) The human interleukin-6 receptor alpha chain gene is localized on chromosome 1 band q21. Hum Genet 90:542–544
Esteve E, Villuendas G, Mallolas J et al (2006) Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristic of the metabolic syndrome. Clin Endocrinol (Oxf) 65:88–91
Hamid YH, Urhammer SA, Jensen DP et al (2004) Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites. Diabetes 53:3342–3345
Jiang CQ, Lam TH, Liu B et al (2010) Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD. Obesity (Silver Spring) 18:1969–1974
The Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis. Lancet 379:1214–1224
IL6R Genetics Consortium Emerging Risk Factors Collaboration (2012) Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379:1205–1213
Kareinen A, Viitanen L, Halonen P et al (2001) Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary artery disease. Arterioscler Thromb Vasc Biol 21:1346–1352
Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606
Graham I, Atar D, Borch-Johnsen K et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 28:2375–2414
Elliott P, Chambers JC, Zhang W (2009) Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302:37–48
Casas JP, Shah T, Cooper J (2006) Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 35:922–931
Kivimäki M, Lawlor DA, Eklund C (2007) Mendelian randomization suggests no causal association between C-reactive protein and carotid intima-media thickness in the young Finns study. Arterioscler Thromb Vasc Biol 27:978–979
Kivimäki M, Lawlor DA, Smith GD (2008) Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study. PLoS One 3:e3013
Chen Z, Qian Q, Ma G et al (2009) A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease. Mol Biol Rep 36:889–893
Chen Z, Ding Z, Ma G et al (2011) Sterol regulatory element-binding transcription factor (SREBF)-2, SREBF cleavage-activating protein (SCAP), and premature coronary artery disease in a Chinese population. Mol Biol Rep 38:2895–2901
Quyyumi AA (2006) Women and ischemic heart disease: pathophysiologic implications from the women’s ischemia syndrome evaluation (WISE) Study and future research steps. J Am Coll Cardiol 47:s66–s71
Claassen Mette, Kirsten C, Sybrandy et al (2012) Gender gap in acute coronary heart disease: myth or reality? World J Cardiol 4:36–47
Zhong C, Zhen D, Qi Q et al (2010) A lack of association between adiponectin polymorphisms and coronary artery disease in a Chinese population. Genet Mol Biol 33:428–433
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Zhong Chen and Qi Qian contributed equally to this work.
Rights and permissions
About this article
Cite this article
Chen, Z., Qian, Q., Tang, C. et al. Association of two variants in the interleukin-6 receptor gene and premature coronary heart disease in a Chinese Han population. Mol Biol Rep 40, 1021–1026 (2013). https://doi.org/10.1007/s11033-012-2143-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-2143-5